Redefining splenic dendritic and myeloid cell subsets

Ying Hey, Helen C O'Neill

Research output: Contribution to conferencePosterResearch

Abstract

Spleen is known to contain multiple dendritic and myeloid cell subsets, distinguishable on the basis of phenotype, function and anatomical location. As a result of recent intensive flow cytometric analyses, splenic dendritic cell (DC) subsets are now better characterised than other myeloid subsets. In order to identify and fully characterise a novel splenic subset termed 'L-DC' in relation to other myeloid cells, it was necessary to investigate myeloid subsets in more detail. In terms of cell surface phenotype, L-DC were initially characterised as a CD11bhiCD11cloMHCII−Ly6C−Ly6G− subset in murine spleen. Their expression of CD43, lack of MHCII, and a low level of CD11c was shown to best differentiate L-DC by phenotype from conventional DC subsets. A complete analysis of all subsets in spleen led to the classification of CD11bhiCD11cloMHCII−Ly6CloLy6G− cells as monocytes expressing CX3CR1, CD43 and CD115. Siglec-F expression was used to identify a specific eosinophil population, distinguishable from both Ly6Clo and Ly6Chi monocytes, and other DC subsets. L-DC were characterised as a clear subset of CD11bhiCD11cloMHCII−Ly6C−Ly6G− cells, which are CD43+, Siglec-F− and CD115−. Changes in the prevalence of L-DC compared to other subsets in spleens of mutant mice confirmed the phenotypic distinction between L-DC, cDC and monocyte subsets. L-DC development in vivo was shown to occur independently of the BATF3 transcription factor that regulates cDC development, and also independently of the FLT3L and GM-CSF growth factors which drive cDC and monocyte development, so distinguishing L-DC from these commonly defined cell types.
Original languageEnglish
Publication statusPublished - Nov 2016
EventThe 55th Australian Society for Medical Research National Scientific Conference: Next Generation Healthcare: Merging Biology & Technology - Bond University, Gold Coast, Australia
Duration: 13 Nov 201615 Nov 2016
Conference number: 55th
http://www.asmr-nsc.org.au/

Conference

ConferenceThe 55th Australian Society for Medical Research National Scientific Conference
Abbreviated titleASMR NSC
CountryAustralia
CityGold Coast
Period13/11/1615/11/16
Internet address

Fingerprint

Myeloid Cells
Dendritic Cells
Monocytes
Sialic Acid Binding Immunoglobulin-like Lectins
Spleen
Phenotype
Granulocyte-Macrophage Colony-Stimulating Factor
Eosinophils
Intercellular Signaling Peptides and Proteins
Transcription Factors

Cite this

Hey, Y., & O'Neill, H. C. (2016). Redefining splenic dendritic and myeloid cell subsets. Poster session presented at The 55th Australian Society for Medical Research National Scientific Conference, Gold Coast, Australia.
Hey, Ying ; O'Neill, Helen C. / Redefining splenic dendritic and myeloid cell subsets. Poster session presented at The 55th Australian Society for Medical Research National Scientific Conference, Gold Coast, Australia.
@conference{d86f08bb2ef94bd2810873d510aaccfc,
title = "Redefining splenic dendritic and myeloid cell subsets",
abstract = "Spleen is known to contain multiple dendritic and myeloid cell subsets, distinguishable on the basis of phenotype, function and anatomical location. As a result of recent intensive flow cytometric analyses, splenic dendritic cell (DC) subsets are now better characterised than other myeloid subsets. In order to identify and fully characterise a novel splenic subset termed 'L-DC' in relation to other myeloid cells, it was necessary to investigate myeloid subsets in more detail. In terms of cell surface phenotype, L-DC were initially characterised as a CD11bhiCD11cloMHCII−Ly6C−Ly6G− subset in murine spleen. Their expression of CD43, lack of MHCII, and a low level of CD11c was shown to best differentiate L-DC by phenotype from conventional DC subsets. A complete analysis of all subsets in spleen led to the classification of CD11bhiCD11cloMHCII−Ly6CloLy6G− cells as monocytes expressing CX3CR1, CD43 and CD115. Siglec-F expression was used to identify a specific eosinophil population, distinguishable from both Ly6Clo and Ly6Chi monocytes, and other DC subsets. L-DC were characterised as a clear subset of CD11bhiCD11cloMHCII−Ly6C−Ly6G− cells, which are CD43+, Siglec-F− and CD115−. Changes in the prevalence of L-DC compared to other subsets in spleens of mutant mice confirmed the phenotypic distinction between L-DC, cDC and monocyte subsets. L-DC development in vivo was shown to occur independently of the BATF3 transcription factor that regulates cDC development, and also independently of the FLT3L and GM-CSF growth factors which drive cDC and monocyte development, so distinguishing L-DC from these commonly defined cell types.",
author = "Ying Hey and O'Neill, {Helen C}",
year = "2016",
month = "11",
language = "English",
note = "The 55th Australian Society for Medical Research National Scientific Conference : Next Generation Healthcare: Merging Biology & Technology, ASMR NSC ; Conference date: 13-11-2016 Through 15-11-2016",
url = "http://www.asmr-nsc.org.au/",

}

Hey, Y & O'Neill, HC 2016, 'Redefining splenic dendritic and myeloid cell subsets' The 55th Australian Society for Medical Research National Scientific Conference, Gold Coast, Australia, 13/11/16 - 15/11/16, .

Redefining splenic dendritic and myeloid cell subsets. / Hey, Ying; O'Neill, Helen C.

2016. Poster session presented at The 55th Australian Society for Medical Research National Scientific Conference, Gold Coast, Australia.

Research output: Contribution to conferencePosterResearch

TY - CONF

T1 - Redefining splenic dendritic and myeloid cell subsets

AU - Hey, Ying

AU - O'Neill, Helen C

PY - 2016/11

Y1 - 2016/11

N2 - Spleen is known to contain multiple dendritic and myeloid cell subsets, distinguishable on the basis of phenotype, function and anatomical location. As a result of recent intensive flow cytometric analyses, splenic dendritic cell (DC) subsets are now better characterised than other myeloid subsets. In order to identify and fully characterise a novel splenic subset termed 'L-DC' in relation to other myeloid cells, it was necessary to investigate myeloid subsets in more detail. In terms of cell surface phenotype, L-DC were initially characterised as a CD11bhiCD11cloMHCII−Ly6C−Ly6G− subset in murine spleen. Their expression of CD43, lack of MHCII, and a low level of CD11c was shown to best differentiate L-DC by phenotype from conventional DC subsets. A complete analysis of all subsets in spleen led to the classification of CD11bhiCD11cloMHCII−Ly6CloLy6G− cells as monocytes expressing CX3CR1, CD43 and CD115. Siglec-F expression was used to identify a specific eosinophil population, distinguishable from both Ly6Clo and Ly6Chi monocytes, and other DC subsets. L-DC were characterised as a clear subset of CD11bhiCD11cloMHCII−Ly6C−Ly6G− cells, which are CD43+, Siglec-F− and CD115−. Changes in the prevalence of L-DC compared to other subsets in spleens of mutant mice confirmed the phenotypic distinction between L-DC, cDC and monocyte subsets. L-DC development in vivo was shown to occur independently of the BATF3 transcription factor that regulates cDC development, and also independently of the FLT3L and GM-CSF growth factors which drive cDC and monocyte development, so distinguishing L-DC from these commonly defined cell types.

AB - Spleen is known to contain multiple dendritic and myeloid cell subsets, distinguishable on the basis of phenotype, function and anatomical location. As a result of recent intensive flow cytometric analyses, splenic dendritic cell (DC) subsets are now better characterised than other myeloid subsets. In order to identify and fully characterise a novel splenic subset termed 'L-DC' in relation to other myeloid cells, it was necessary to investigate myeloid subsets in more detail. In terms of cell surface phenotype, L-DC were initially characterised as a CD11bhiCD11cloMHCII−Ly6C−Ly6G− subset in murine spleen. Their expression of CD43, lack of MHCII, and a low level of CD11c was shown to best differentiate L-DC by phenotype from conventional DC subsets. A complete analysis of all subsets in spleen led to the classification of CD11bhiCD11cloMHCII−Ly6CloLy6G− cells as monocytes expressing CX3CR1, CD43 and CD115. Siglec-F expression was used to identify a specific eosinophil population, distinguishable from both Ly6Clo and Ly6Chi monocytes, and other DC subsets. L-DC were characterised as a clear subset of CD11bhiCD11cloMHCII−Ly6C−Ly6G− cells, which are CD43+, Siglec-F− and CD115−. Changes in the prevalence of L-DC compared to other subsets in spleens of mutant mice confirmed the phenotypic distinction between L-DC, cDC and monocyte subsets. L-DC development in vivo was shown to occur independently of the BATF3 transcription factor that regulates cDC development, and also independently of the FLT3L and GM-CSF growth factors which drive cDC and monocyte development, so distinguishing L-DC from these commonly defined cell types.

M3 - Poster

ER -

Hey Y, O'Neill HC. Redefining splenic dendritic and myeloid cell subsets. 2016. Poster session presented at The 55th Australian Society for Medical Research National Scientific Conference, Gold Coast, Australia.